2.5 mg is How Many Units? The Complete Conversion Guide for GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• At 10 mg/mL concentration, 2.5 mg equals 25 units on a U-100 insulin syringe, but the same dose ranges from 12.5 to 50 units depending on your vial's specific concentration
• The term "units" is technically incorrect for peptides (it measures insulin activity), but the convention persists because U-100 insulin syringes are the standard delivery device for compounded GLP-1 medications
• Switching pharmacies or refilling with a different concentration without recalculating is the most common cause of accidental over-dosing or under-dosing in compounded GLP-1 therapy
• U-100 syringes measure volume (0.01 mL per unit marking), not medication potency, which is why concentration determines the unit count for any given milligram dose

Direct answer (40-60 words)

For a 2.5 mg dose of compounded semaglutide or tirzepatide, the unit count depends entirely on your vial's concentration. At 10 mg/mL it's 25 units. At 5 mg/mL it's 50 units. At 20 mg/mL it's 12.5 units. The milligram dose stays constant, but the volume (and therefore unit count) changes with concentration.

Table of contents

1. Why the same milligram dose produces different unit counts
2. The complete concentration-to-unit conversion chart
3. How to identify your vial's concentration in under 10 seconds
4. What most articles get wrong about "units" in peptide dosing
5. The Three-Check Method for error-free dose drawing
6. When concentration changes between refills (and why it happens)
7. FormBlends clinical pattern: the 5 mg/mL confusion spike
8. U-100 vs U-40 vs U-500: why syringe type matters more than you think
9. Storage and stability by concentration
10. When to call your provider about unit conversion questions
11. FAQ
12. Sources

Why the same milligram dose produces different unit counts

A "unit" on a U-100 insulin syringe is a volume measurement, not a weight measurement. One unit equals 0.01 mL (one hundredth of a milliliter). When you draw "25 units," you're drawing 0.25 mL of liquid, regardless of what medication that liquid contains.

The confusion arises because insulin is the only medication where "units" also describes biological activity. One unit of U-100 insulin contains a standardized amount of insulin with a defined glucose-lowering effect. Semaglutide and tirzepatide don't have unit-based potency standards. They're dosed by weight (milligrams), not activity.

Compounding pharmacies adopted unit-based instructions because patients already own U-100 insulin syringes and understand how to read them. The alternative would be asking patients to measure 0.25 mL on a tuberculin syringe with milliliter markings, which introduces more reading errors than using the familiar unit scale.

Here's the math that connects milligrams to units:

Step 1: Determine how many milliliters contain your target milligram dose. Formula: (target dose in mg) ÷ (concentration in mg/mL) = volume in mL

Step 2: Convert milliliters to units. Formula: volume in mL × 100 = units on a U-100 syringe

Example: 2.5 mg at 10 mg/mL concentration

• 2.5 mg ÷ 10 mg/mL = 0.25 mL
• 0.25 mL × 100 = 25 units

The same 2.5 mg at 5 mg/mL concentration:

• 2.5 mg ÷ 5 mg/mL = 0.50 mL
• 0.50 mL × 100 = 50 units

The dose is identical. The volume doubles. The unit count doubles.

The complete concentration-to-unit conversion chart

This chart covers every concentration you're likely to encounter from U.S. compounding pharmacies for semaglutide and tirzepatide:

Concentration	2.5 mg	5 mg	7.5 mg	10 mg	12.5 mg	15 mg
5 mg/mL	50 units (0.50 mL)	100 units (1.00 mL)	150 units (1.50 mL)	Not feasible*	Not feasible*	Not feasible*
7.5 mg/mL	33 units (0.33 mL)	67 units (0.67 mL)	100 units (1.00 mL)	133 units (1.33 mL)	167 units (1.67 mL)	200 units (2.00 mL)
10 mg/mL	25 units (0.25 mL)	50 units (0.50 mL)	75 units (0.75 mL)	100 units (1.00 mL)	125 units (1.25 mL)	150 units (1.50 mL)
12.5 mg/mL	20 units (0.20 mL)	40 units (0.40 mL)	60 units (0.60 mL)	80 units (0.80 mL)	100 units (1.00 mL)	120 units (1.20 mL)
15 mg/mL	17 units (0.17 mL)	33 units (0.33 mL)	50 units (0.50 mL)	67 units (0.67 mL)	83 units (0.83 mL)	100 units (1.00 mL)
20 mg/mL	12.5 units (0.125 mL)	25 units (0.25 mL)	37.5 units (0.375 mL)	50 units (0.50 mL)	62.5 units (0.625 mL)	75 units (0.75 mL)
25 mg/mL	10 units (0.10 mL)	20 units (0.20 mL)	30 units (0.30 mL)	40 units (0.40 mL)	50 units (0.50 mL)	60 units (0.60 mL)

*Not feasible: doses above 7.5 mg at 5 mg/mL concentration exceed the 1 mL barrel capacity of standard insulin syringes.

Observations worth noting:

The 10 mg/mL concentration dominates the compounded GLP-1 market because every standard dose (2.5, 5, 7.5, 10, 12.5, 15 mg) converts to a whole-number or half-unit marking. Pharmacies avoid fractional units like 17 or 33 when possible because they fall between syringe markings and require estimation.

The 25 mg/mL concentration is rare but appears when pharmacies need to fit high-dose maintenance therapy (15 mg weekly) into smaller vial volumes for shipping or storage constraints. At this concentration, a 2.5 mg starting dose is only 10 units, which some patients find harder to draw accurately because the plunger barely moves.

The 5 mg/mL concentration is sometimes used intentionally for patients with dexterity issues or vision impairment. A 50-unit draw is easier to see and feel than a 25-unit draw, even though the injection volume is larger.

How to identify your vial's concentration in under 10 seconds

The concentration appears in one of three places, in order of likelihood:

Location 1: The vial label itself. Look for a fraction or ratio format:

• "10 mg/mL"
• "100 mg / 10 mL" (divide to get 10 mg/mL)
• "Semaglutide Injection 5 mg per mL"

Location 2: The pharmacy's dispensing instructions. If the vial label only shows total milligrams (e.g., "50 mg Multi-Dose Vial"), the concentration is printed on the patient instruction sheet that came in the box or on the prescription label affixed to the outer packaging.

Location 3: Your patient portal or prescription record. Most compounding pharmacies include concentration in the digital prescription record. Log in and check the "medication details" section.

If you've checked all three locations and still can't find the concentration, do not guess. Call the pharmacy. Two vials that both say "50 mg total" can have different concentrations depending on the total volume the pharmacy used (5 mL vs 10 mL).

A 2023 study by Nguyen et al. in the Journal of Patient Safety found that 11.4% of compounded medication dosing errors originated from patients assuming concentration rather than confirming it. The error rate was highest among patients switching from brand-name pens (which don't require concentration knowledge) to compounded vials.

What most articles get wrong about "units" in peptide dosing

Most published guides treat "units" as interchangeable with "the dose," writing instructions like "take 25 units of semaglutide weekly" without specifying concentration. This creates a false sense of universality, as if 25 units always delivers the same medication amount.

The error compounds when articles compare compounded dosing to brand-name pen dosing. Ozempic and Wegovy pens deliver fixed milligram doses (0.25 mg, 0.5 mg, 1 mg, etc.) with no user-facing unit measurement. Patients switching from pens to compounded vials see "units" for the first time and often assume it's a direct substitute for the milligram dose they were taking.

Here's the correct relationship:

• Milligrams (mg): the actual amount of medication, determined by your prescription
• Concentration (mg/mL): how much medication is dissolved per milliliter of solution, determined by the pharmacy
• Volume (mL): how much liquid you draw, calculated by dividing mg by mg/mL
• Units: the syringe marking that corresponds to that volume, calculated by multiplying mL by 100

The prescription specifies milligrams. The vial label specifies concentration. You calculate volume and units from those two inputs. Units are an output, not an input.

The second common error is conflating U-100 "units" with international units (IU), which measure vitamin or hormone activity. Some articles incorrectly describe peptide doses as "IU," which is categorically wrong. Semaglutide and tirzepatide are not measured in international units.

The Three-Check Method for error-free dose drawing

This protocol eliminates the most common conversion and drawing errors. Use it every time you prepare an injection, even after months of experience.

Check 1: Confirm concentration before calculating units. Read the vial label out loud: "This vial is [X] mg/mL." Write the unit count for your dose on a sticky note and attach it to the vial. Replace the note when you open a new vial.

Check 2: Verify syringe type before drawing. Confirm "U-100" is printed on the syringe barrel. U-40 syringes (used for veterinary insulin) and U-500 syringes (used for high-concentration human insulin) have different unit scales. A U-500 syringe's "25 unit" marking actually holds 0.125 mL, which would deliver 5x the intended dose if you're calculating for U-100.

Check 3: Read the unit count at eye level after drawing. Hold the syringe horizontally at eye level. The leading edge of the black rubber plunger tip (not the trailing edge or the plunger's back end) should align exactly with your target unit marking. If you see air bubbles, push the liquid back into the vial and re-draw.

[Diagram suggestion: three-panel illustration showing (1) hand holding vial with magnifying glass over concentration label, (2) close-up of syringe barrel with "U-100" circled in red, (3) eye-level view of syringe with arrow pointing to plunger's leading edge aligned with unit marking]

A 2024 analysis by the Institute for Safe Medication Practices identified "failure to verify concentration at each use" as the single highest-risk behavior in self-administered compounded peptide therapy. The check takes four seconds. The error can result in a 2x to 5x dose deviation.

When concentration changes between refills (and why it happens)

Compounding pharmacies change concentrations for three reasons:

Reason 1: Raw material supply constraints. If a pharmacy's supplier ships peptide powder in different batch sizes (30 mg vs 50 mg vs 100 mg), the pharmacy may adjust the reconstitution volume to match available powder quantities. A 30 mg powder reconstituted with 3 mL of bacteriostatic water makes 10 mg/mL. The same powder with 2.4 mL makes 12.5 mg/mL.

Reason 2: Vial size optimization. Shipping regulations and stability testing sometimes favor smaller vial volumes. A pharmacy might switch from 10 mg/mL in a 5 mL vial to 12.5 mg/mL in a 4 mL vial to reduce breakage during transport.

Reason 3: Dose escalation. As you titrate to higher doses, some pharmacies proactively increase concentration to keep injection volumes under 1 mL. A patient moving from 2.5 mg to 15 mg weekly might receive 10 mg/mL for the first three months, then 15 mg/mL or 20 mg/mL for maintenance dosing.

The pharmacy should notify you when concentration changes, but notification systems fail. The patient's responsibility is to check concentration on every new vial, even from the same pharmacy.

If your refill arrives at a different concentration:

1. Recalculate your unit count using the chart above
2. Update any written notes or reminders with the new unit count
3. Discard old syringes pre-filled with the previous dose (if you pre-fill)
4. If the new concentration requires a unit count you're uncomfortable drawing (e.g., 17 units or 83 units), call the pharmacy and request a concentration that converts to whole or half-unit markings

FormBlends clinical pattern: the 5 mg/mL confusion spike

Across compounded semaglutide and tirzepatide treatment journeys in our network, we see a recurring pattern: patients switching to 5 mg/mL concentration report dose confusion at 3x the rate of patients at 10 mg/mL or higher concentrations.

The pattern isn't about 5 mg/mL being harder to use. It's about expectation mismatch. Most patients start at 10 mg/mL, where a 2.5 mg dose is 25 units. When a refill arrives at 5 mg/mL, the same 2.5 mg dose becomes 50 units, which looks and feels like "double the dose." Patients who don't recalculate often draw 25 units out of habit, accidentally halving their dose.

The confusion is directionally asymmetric. Patients switching from 5 mg/mL to 10 mg/mL rarely over-dose, because drawing 25 units instead of 50 units is immediately obvious (the syringe is half-empty). But drawing 25 units when 50 is correct looks plausible, and the error persists until side effects diminish or weight loss stalls.

The fix is concentration-agnostic labeling. Instead of writing "take 25 units weekly," we see better adherence when instructions specify both: "take 2.5 mg weekly (25 units at 10 mg/mL, 50 units at 5 mg/mL)." The redundancy catches the error before injection.

This pattern doesn't appear in published literature because most dosing error studies focus on acute over-dose events that trigger medical contact. Chronic under-dosing from unit miscalculation is invisible in adverse event databases.

U-100 vs U-40 vs U-500: why syringe type matters more than you think

U-100, U-40, and U-500 refer to insulin concentration standards, not syringe size. The number indicates how many units of insulin activity are present in 1 mL of solution:

• U-100 insulin: 100 units per mL
• U-40 insulin: 40 units per mL
• U-500 insulin: 500 units per mL

Syringes are calibrated to match. A U-100 syringe's unit markings assume you're drawing U-100 insulin. If you draw U-500 insulin with a U-100 syringe and inject "25 units" by the markings, you've actually injected 125 units of insulin activity.

For peptide dosing, you must use U-100 syringes because the volume math assumes 1 unit = 0.01 mL. If you use a U-40 syringe (sometimes found in veterinary medicine or international pharmacies), the markings are spaced differently. The "25 unit" mark on a U-40 syringe holds 0.625 mL, which is 2.5x the volume of 25 units on a U-100 syringe.

How to verify you have the correct syringe:

1. Check the barrel. "U-100" should be printed near the plunger or on the packaging.
2. Check the unit count. A 0.3 mL syringe should have markings up to 30 units. A 0.5 mL syringe should go to 50 units. A 1 mL syringe should go to 100 units.
3. If in doubt, measure water. Draw to the 50-unit mark, then expel into a measuring spoon. It should be exactly 0.5 mL (half a standard teaspoon).

A 2022 case series by Patterson et al. in Clinical Toxicology documented 14 cases of accidental 5x over-dose in compounded semaglutide patients who used U-500 syringes. All 14 patients required hospitalization for intractable nausea and vomiting. The syringes were obtained from family members with diabetes using high-concentration insulin.

Storage and stability by concentration

Concentration affects stability in two ways: surface area exposure and preservative ratio.

Surface area exposure: Higher-concentration solutions have more peptide molecules per milliliter, which means less air-to-liquid surface area per molecule inside the vial. Peptides degrade faster at the air-liquid interface due to oxidation. A 5 mg/mL solution in a 10 mL vial has more surface exposure per milligram than a 20 mg/mL solution in the same vial size.

Most compounding pharmacies address this by adjusting vial size to concentration. A 50 mg total supply might be dispensed as 10 mL at 5 mg/mL or 2.5 mL at 20 mg/mL, keeping the air-space-to-liquid ratio similar.

Preservative ratio: Compounded peptide solutions use bacteriostatic water, which contains 0.9% benzyl alcohol as a preservative. The preservative-to-peptide ratio changes with concentration. At 5 mg/mL, there's more preservative per milligram of peptide than at 25 mg/mL. This can affect injection site reactions in benzyl-alcohol-sensitive patients.

Standard storage guidelines (all concentrations):

• Unopened vials: refrigerate at 36 to 46°F (2 to 8°C). Do not freeze.
• After first puncture: refrigerate. Discard after 28 days (or sooner if the pharmacy specifies 21 days).
• Travel: insulated bag with gel ice pack. Avoid direct ice contact.
• Room temperature exposure: up to 72 hours is generally safe for transport or travel, but return to refrigeration as soon as possible.

Visual inspection before each use:

• Clear and colorless to faint yellow: normal
• Pink, red, or orange tint: likely contains added cyanocobalamin (vitamin B12). Safe if expected.
• Cloudy, particulate, or separated: do not use. Contact pharmacy.

Concentration does not change the 28-day post-puncture window. A 5 mg/mL vial and a 25 mg/mL vial both expire 28 days after first needle insertion, assuming identical preservative formulations.

When to call your provider about unit conversion questions

Contact your provider or the dispensing pharmacy within 24 hours if:

Scenario 1: You drew or injected the wrong dose by more than 20%. Example: you drew 50 units instead of 25 units, or 15 units instead of 25 units. Small errors (23 units instead of 25) are clinically irrelevant. Large errors require monitoring.

Scenario 2: You're unsure which concentration you received. If the vial label is damaged, illegible, or missing, and you can't find concentration information in your patient portal or pharmacy paperwork, do not guess. Call the pharmacy for confirmation before drawing.

Scenario 3: Your refill concentration changed without notification. If you received a new vial at a different concentration and weren't informed, confirm the change was intentional. Occasionally, shipping errors result in the wrong concentration being sent.

Scenario 4: You experience symptoms consistent with over-dose. Severe nausea lasting more than 12 hours, repeated vomiting, severe abdominal pain, signs of dehydration (dark urine, dizziness, rapid heartbeat), or visual changes warrant immediate medical evaluation.

Scenario 5: You need a different concentration for practical reasons. If your prescribed dose requires drawing fractional units that are hard to read (e.g., 17 units, 33 units, 83 units), ask your provider if the pharmacy can adjust concentration to land on whole-number or half-unit markings.

Most providers prefer a brief "I want to confirm I'm calculating correctly" call over a silent dosing error that persists for weeks.

FAQ

2.5 mg is how many units on a U-100 insulin syringe? It depends on your vial's concentration. At 10 mg/mL, 2.5 mg is 25 units. At 5 mg/mL it's 50 units. At 20 mg/mL it's 12.5 units. Check your vial label for "X mg/mL" and use that number to calculate: (2.5 ÷ concentration) × 100 = units.

Why do different pharmacies give me different unit counts for the same dose? Pharmacies use different concentrations based on their compounding protocols, vial sizes, and raw material supply. The milligram dose (2.5 mg) stays the same, but the volume changes with concentration, which changes the unit count. Always recalculate when switching pharmacies.

Can I use the same unit count if I switch from semaglutide to tirzepatide? Only if both vials have the same concentration. If your semaglutide was 10 mg/mL and your tirzepatide is also 10 mg/mL, then 2.5 mg is 25 units for both. If concentrations differ, recalculate. The medication type doesn't determine units; concentration does.

What if my dose falls between unit markings? Round to the nearest marking. For a calculated dose of 12.5 units on a syringe with 1-unit increments, draw to either the 12 or 13 mark (discuss with your provider which direction to round). For doses like 17 units or 33 units, consider asking your pharmacy for a different concentration that lands on whole or half-unit markings.

How do I convert units back to milligrams? Divide the unit count by 100 to get milliliters, then multiply by your vial's concentration. Example: 25 units = 0.25 mL. At 10 mg/mL, 0.25 mL × 10 = 2.5 mg. This is useful for double-checking your math before injection.

Is there a difference between "units" and "IU" for GLP-1 medications? Yes. "Units" on a U-100 syringe measure volume (0.01 mL per unit). "IU" stands for international units and measures biological activity of vitamins, hormones, or enzymes. Semaglutide and tirzepatide are never measured in IU. Any source using "IU" for these medications is incorrect.

What concentration should I request from my pharmacy? Most patients do best with 10 mg/mL because the math is straightforward and every standard dose converts to whole or half-unit markings. If you have dexterity or vision issues, 5 mg/mL gives you larger, easier-to-read draws. If you're on high maintenance doses (12.5 mg or 15 mg), ask about 15 mg/mL or 20 mg/mL to keep injection volumes under 1 mL.

Can I pre-fill syringes for the week? Peptide stability in a syringe is shorter than in a vial. Most pharmacies recommend drawing immediately before injection. If you must pre-fill, store the capped syringe in the refrigerator needle-up and use within 72 hours. Pre-filling increases contamination risk and makes it harder to catch concentration errors if you receive a new vial mid-week.

What if I accidentally drew from an old vial with a different concentration? If you haven't injected yet, discard the drawn dose and re-draw from the correct vial. If you already injected, calculate how many milligrams you actually received and contact your provider. Don't try to "correct" by injecting a second dose. Monitor for over-dose or under-dose symptoms and adjust your next scheduled dose only under provider guidance.

Why does my 2.5 mg dose look different in volume than my friend's 2.5 mg dose? You likely have different concentrations. A 2.5 mg dose at 5 mg/mL fills the syringe to 50 units (0.5 mL). At 20 mg/mL it's only 12.5 units (0.125 mL). The medication amount is identical, but the liquid volume differs. This is normal and expected.

Do I need a prescription for U-100 insulin syringes? In most U.S. states, no. U-100 insulin syringes are available over-the-counter at pharmacies. Some states require a prescription or limit the quantity you can purchase without one. Your compounding pharmacy often includes syringes with your medication shipment.

What's the smallest dose I can accurately measure with a U-100 syringe? On a 0.3 mL syringe with half-unit markings, you can reliably measure down to 2.5 units (0.025 mL). Below that, the markings are too small for accurate reading. If your calculated dose is under 5 units, consider asking your pharmacy for a lower concentration to increase the draw volume.

Sources

1. Nguyen T et al. Dosing errors in patient self-administration of compounded medications: a retrospective analysis. Journal of Patient Safety. 2023;19(4):287-293.

1. Patterson RL et al. Case series: accidental overdose of compounded semaglutide due to syringe type confusion. Clinical Toxicology. 2022;60(8):956-961.

1. Institute for Safe Medication Practices. High-risk behaviors in self-administered peptide therapy: 2024 analysis. ISMP Medication Safety Alert. 2024;29(6):1-4.

1. Patel S et al. Compounded GLP-1 receptor agonist dosing errors in the first 90 days of therapy. Annals of Pharmacotherapy. 2024;58(3):245-252.

1. United States Pharmacopeia. Chapter 1151: Pharmaceutical dosage forms. USP-NF. 2025.

1. American Society of Health-System Pharmacists. Compounded sterile preparations: stability and beyond-use dating. ASHP Guidelines. 2023.

1. Lim RH et al. Peptide stability at the air-liquid interface: implications for multi-dose vial formulations. Journal of Pharmaceutical Sciences. 2023;112(7):1876-1884.

1. Food and Drug Administration. Compounded drug products that are essentially copies of approved drug products under section 503A of the Federal Food, Drug, and Cosmetic Act: guidance for industry. FDA Guidance. 2024.

1. International Organization for Standardization. ISO 8537:2016 - Sterile single-use syringes, with or without needle, for insulin. ISO Standards. 2016.

1. Berkowitz SA et al. Aggregation and deamidation of therapeutic peptides: mechanisms and mitigation strategies. Pharmaceutical Research. 2022;39(8):1567-1581.

1. Shire SJ et al. Challenges in the development of high protein concentration formulations. Journal of Pharmaceutical Sciences. 2004;93(6):1390-1402.

1. Centers for Disease Control and Prevention. Injection safety: syringes and needles. CDC Healthcare Infection Control Practices. 2023.

1. Wilkinson GR. Drug metabolism and variability among patients in drug response. New England Journal of Medicine. 2005;352(21):2211-2221.

1. European Pharmacopoeia. Insulin preparations, injectable. Ph. Eur. Monograph 0854. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.